Clinical effects of COVID-19 vaccines on chronic spontaneous urticaria patients: a study on two Turkish centers
BackgroundThe relationship between CSU and vaccines is reported in the literature. The post-vaccine clinical effect of COVİD-19 vaccines on CSU patients is still unclear. we aimed to evaluate clinical effects of COVID-19 Vaccines on CSU patients.Materials and methodsCSU patients under treatment and...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-09-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2023.1222126/full |
| _version_ | 1797671442565824512 |
|---|---|
| author | Demet Kartal Shahzada Orujova Ragıp Ertaş |
| author_facet | Demet Kartal Shahzada Orujova Ragıp Ertaş |
| author_sort | Demet Kartal |
| collection | DOAJ |
| description | BackgroundThe relationship between CSU and vaccines is reported in the literature. The post-vaccine clinical effect of COVİD-19 vaccines on CSU patients is still unclear. we aimed to evaluate clinical effects of COVID-19 Vaccines on CSU patients.Materials and methodsCSU patients under treatment and follow-up in our outpatient clinic were evaluated retrospectively. To determine disease activity the urticaria activity score over seven days (UAS7) was used. The details of demographic information, CSU treatment, history of COVID-19 infection and exacerbation of urticaria during infection, COVID-19 vaccinations, type of vaccine, side effect reaction time after vaccination, hospital admission requirement were also assessed.ResultsTotal of 190 patients with a mean age of The mean age of patients was 41,7±14,0 years (range = 18–72) were enrooled. The patient sample consisted of 50 males and 140 females (male/female ratio 1:2.8). 181 (CoronaVac 77, Pfizer-BioNTech 104) patients were vaccinated. Urticarial exacerbation was occurred in 25 patients. The median UAS value was 5 before vaccination, it was 12 in patients with post-vaccine urticaria. Two patients had angioedema and one patient had anaphylaxis after vaccinated with Pfizer-BioNTech.ConclusionCOVID-19 vaccination in the CSU can be considered safe. Cases with urticarial exacerbation appear to be transient and can be managed by antihistamine and/or systemic steroid therapies. More extensive studies are needed for the relationship with CSU and post-coronavirus vaccination anaphylaxy. |
| first_indexed | 2024-03-11T21:15:35Z |
| format | Article |
| id | doaj.art-0edbad71b6094f8fa00f6b0f8e879723 |
| institution | Directory Open Access Journal |
| issn | 2296-858X |
| language | English |
| last_indexed | 2024-03-11T21:15:35Z |
| publishDate | 2023-09-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Medicine |
| spelling | doaj.art-0edbad71b6094f8fa00f6b0f8e8797232023-09-29T04:09:54ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2023-09-011010.3389/fmed.2023.12221261222126Clinical effects of COVID-19 vaccines on chronic spontaneous urticaria patients: a study on two Turkish centersDemet Kartal0Shahzada Orujova1Ragıp Ertaş2Dermatology and Venereology Department, Erciyes University Medical School, Kayseri, TürkiyeDermatology and Venereology Department, Erciyes University Medical School, Kayseri, TürkiyeKayseri City Hospital Kayseri, Kayseri, TürkiyeBackgroundThe relationship between CSU and vaccines is reported in the literature. The post-vaccine clinical effect of COVİD-19 vaccines on CSU patients is still unclear. we aimed to evaluate clinical effects of COVID-19 Vaccines on CSU patients.Materials and methodsCSU patients under treatment and follow-up in our outpatient clinic were evaluated retrospectively. To determine disease activity the urticaria activity score over seven days (UAS7) was used. The details of demographic information, CSU treatment, history of COVID-19 infection and exacerbation of urticaria during infection, COVID-19 vaccinations, type of vaccine, side effect reaction time after vaccination, hospital admission requirement were also assessed.ResultsTotal of 190 patients with a mean age of The mean age of patients was 41,7±14,0 years (range = 18–72) were enrooled. The patient sample consisted of 50 males and 140 females (male/female ratio 1:2.8). 181 (CoronaVac 77, Pfizer-BioNTech 104) patients were vaccinated. Urticarial exacerbation was occurred in 25 patients. The median UAS value was 5 before vaccination, it was 12 in patients with post-vaccine urticaria. Two patients had angioedema and one patient had anaphylaxis after vaccinated with Pfizer-BioNTech.ConclusionCOVID-19 vaccination in the CSU can be considered safe. Cases with urticarial exacerbation appear to be transient and can be managed by antihistamine and/or systemic steroid therapies. More extensive studies are needed for the relationship with CSU and post-coronavirus vaccination anaphylaxy.https://www.frontiersin.org/articles/10.3389/fmed.2023.1222126/fullangioedemachronic urticaria (CU)anaphylaxisCOVID-19 vaccinationvaccination |
| spellingShingle | Demet Kartal Shahzada Orujova Ragıp Ertaş Clinical effects of COVID-19 vaccines on chronic spontaneous urticaria patients: a study on two Turkish centers Frontiers in Medicine angioedema chronic urticaria (CU) anaphylaxis COVID-19 vaccination vaccination |
| title | Clinical effects of COVID-19 vaccines on chronic spontaneous urticaria patients: a study on two Turkish centers |
| title_full | Clinical effects of COVID-19 vaccines on chronic spontaneous urticaria patients: a study on two Turkish centers |
| title_fullStr | Clinical effects of COVID-19 vaccines on chronic spontaneous urticaria patients: a study on two Turkish centers |
| title_full_unstemmed | Clinical effects of COVID-19 vaccines on chronic spontaneous urticaria patients: a study on two Turkish centers |
| title_short | Clinical effects of COVID-19 vaccines on chronic spontaneous urticaria patients: a study on two Turkish centers |
| title_sort | clinical effects of covid 19 vaccines on chronic spontaneous urticaria patients a study on two turkish centers |
| topic | angioedema chronic urticaria (CU) anaphylaxis COVID-19 vaccination vaccination |
| url | https://www.frontiersin.org/articles/10.3389/fmed.2023.1222126/full |
| work_keys_str_mv | AT demetkartal clinicaleffectsofcovid19vaccinesonchronicspontaneousurticariapatientsastudyontwoturkishcenters AT shahzadaorujova clinicaleffectsofcovid19vaccinesonchronicspontaneousurticariapatientsastudyontwoturkishcenters AT ragıpertas clinicaleffectsofcovid19vaccinesonchronicspontaneousurticariapatientsastudyontwoturkishcenters |